Home › Idiopathic Hypersomnia › Alabama
Idiopathic Hypersomnia clinical trials in Alabama
4 studies for Idiopathic Hypersomnia are looking for participants at sites in Alabama.
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Sleep Disorders Center of Alabama, Birmingham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07500090A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Cullman
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Aug 7, 2026 · NCT06767683A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Auburn, Alabama, Auburn
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 27, 2026 · NCT06752668A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Auburn, alabama, Auburn
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 16, 2026 · NCT07096674From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.